(15055031), A. E., (15055034), L. S., (15055037), S. I. V., (15055040), L. A. H., (14947288), C. A. L., (15055043), V. F., . . . (14947294), C. L. (2025). Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Dyfyniad Arddull Chicago(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.
Dyfyniad MLA(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.